VCYT - ベラサイト (Veracyte Inc.)

VCYTのニュース

   Veracyte announces key leadership promotions to advance strategic global vision  2022/01/06 13:36:53 Seeking Alpha
Veracyte (VCYT) announces key leadership promotions that further position the company to achieve its strategic global vision.Effective immediately, Tina Nova, Ph.D., is President
   Veracyte (NASDAQ:VCYT) Stock Price Up 3.4%  2021/12/24 10:06:44 Dakota Financial News
Veracyte, Inc. (NASDAQ:VCYT) rose 3.4% on Wednesday . The company traded as high as $45.14 and last traded at $44.79. Approximately 6,255 shares were traded during trading, a decline of 99% from the average daily volume of 757,466 shares. The stock had previously closed at $43.30. VCYT has been the subject of a number of []
   Karin Eastham Sells 5,000 Shares of Veracyte, Inc. (NASDAQ:VCYT) Stock  2021/12/22 09:28:45 Dakota Financial News
Veracyte, Inc. (NASDAQ:VCYT) Director Karin Eastham sold 5,000 shares of Veracyte stock in a transaction that occurred on Friday, December 17th. The stock was sold at an average price of $45.00, for a total transaction of $225,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed []
   Veracyte Inc. (NASDAQ: VCYT) -8.71% Decline Turns Investors Off From Company Stock  2021/12/21 16:00:00 Stocks Register
Veracyte Inc. (NASDAQ:VCYT) traded at $41.07 at close of the session on Monday, 12/20/21, made a downward move of -8.71% on its previous days price. Looking at the stock we see that its previous close was $44.99 and the beta (5Y monthly) reads 0.77 with the days price range being $40.85 $43.825. In terms Veracyte Inc. (NASDAQ: VCYT) -8.71% Decline Turns Investors Off From Company Stock Read More »
   Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF Diagnosis  2021/12/14 21:05:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF Diagnosis
   Veracyte (NASDAQ:VCYT) Issues Quarterly Earnings Results  2021/11/10 17:28:41 Dakota Financial News
Veracyte (NASDAQ:VCYT) issued its quarterly earnings results on Tuesday. The biotechnology company reported ($0.20) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.14) by ($0.06), MarketWatch Earnings reports. Veracyte had a negative return on equity of 4.05% and a negative net margin of 40.06%. During the same period in the prior year, []
   Veracyte, Inc. (VCYT) CEO Marc Stapley on Q3 2021 Results - Earnings Call Transcript  2021/11/10 04:23:02 Seeking Alpha
   Veracyte EPS misses by $0.03, beats on revenue  2021/11/09 21:26:41 Seeking Alpha
   Veracyte Announces Third Quarter 2021 Financial Results  2021/11/09 21:05:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--Veracyte Announces Third Quarter 2021 Financial Results
   Veracyte Appoints Muna Bhanji to Its Board of Directors  2021/03/22 12:15:00 Business Wire
Veracyte Appoints Muna Bhanji to Its Board of Directors
   3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy  2021/03/16 11:41:00 Benzinga
Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte …
   Veracyte Completes Acquisition of Decipher Biosciences  2021/03/15 12:30:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Completes Acquisition of Decipher Biosciences
   Veracyte Commends New USPSTF Lung Cancer Screening Guidelines - Stocks News Feed  2021/03/10 22:15:00 Stocks News Feed
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT) today commended the U.S. Preventive Services Task Force (USPSTF) for its new, revised recommendations that expand eligibility for lung cancer screening. The updated recommendations lower the age for current and former smokers to begin screening from 55 to 50 years and reduces smoking intensity – from a… Read More »Veracyte Commends New USPSTF Lung Cancer Screening Guidelines
   Veracyte to Present at 10th Annual SVB Leerink Global Healthcare Conference  2021/02/18 21:05:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte to Present at 10th Annual SVB Leerink Global Healthcare Conference

calendar